Contemporary celiac disease diagnosis: Is a biopsy avoidable?

John R. Mills, Joseph A Murray

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

Purpose of review The duodenal biopsy is the gold standard for the diagnosis of celiac disease. However, given improvements in the performance of serological testing, the possibility of accurately diagnosing celiac disease without the need of a biopsy has attracted interest. The European Society for Paediatric Gastroenterology, Hepatology and Nutrition has revised its recommendations to include a diagnostic algorithm that includes sequential serological testing and human leukocyte antigen genotyping for symptomatic children which would enable a diagnosis of celiac disease to be made in the absence of a confirmatory intestinal biopsy. Recent findings Recent studies have evaluated the ESPGHAN guidelines and have mostly corroborated that celiac disease can be accurately diagnosed in specific pediatric patient populations without the need of a biopsy. However, two cautionary points have been raised that warrant further consideration-the success of this approach is highly dependent targeting a population with a high pretest probability of celiac disease, as well, the performance of serology assays must be established and the appropriate use of cutoffs is essential. Summary The duodenal biopsy will remain the gold standard for diagnosing celiac disease in a majority of patients. However, as serology assays evolve and as a greater understanding of the genetic risk factors of celiac disease is achieved, more patients may be accurately diagnosed without the need for a biopsy.

Original languageEnglish (US)
Pages (from-to)80-85
Number of pages6
JournalCurrent Opinion in Gastroenterology
Volume32
Issue number2
DOIs
StatePublished - Mar 1 2016

Fingerprint

Celiac Disease
Biopsy
Serology
HLA Antigens
Population
Guidelines
Pediatrics

Keywords

  • celiac disease
  • human leukocyte antigen
  • intestinal biopsy
  • serology

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Contemporary celiac disease diagnosis : Is a biopsy avoidable? / Mills, John R.; Murray, Joseph A.

In: Current Opinion in Gastroenterology, Vol. 32, No. 2, 01.03.2016, p. 80-85.

Research output: Contribution to journalReview article

@article{ef90f24490804d08b771f8f3c07ddec5,
title = "Contemporary celiac disease diagnosis: Is a biopsy avoidable?",
abstract = "Purpose of review The duodenal biopsy is the gold standard for the diagnosis of celiac disease. However, given improvements in the performance of serological testing, the possibility of accurately diagnosing celiac disease without the need of a biopsy has attracted interest. The European Society for Paediatric Gastroenterology, Hepatology and Nutrition has revised its recommendations to include a diagnostic algorithm that includes sequential serological testing and human leukocyte antigen genotyping for symptomatic children which would enable a diagnosis of celiac disease to be made in the absence of a confirmatory intestinal biopsy. Recent findings Recent studies have evaluated the ESPGHAN guidelines and have mostly corroborated that celiac disease can be accurately diagnosed in specific pediatric patient populations without the need of a biopsy. However, two cautionary points have been raised that warrant further consideration-the success of this approach is highly dependent targeting a population with a high pretest probability of celiac disease, as well, the performance of serology assays must be established and the appropriate use of cutoffs is essential. Summary The duodenal biopsy will remain the gold standard for diagnosing celiac disease in a majority of patients. However, as serology assays evolve and as a greater understanding of the genetic risk factors of celiac disease is achieved, more patients may be accurately diagnosed without the need for a biopsy.",
keywords = "celiac disease, human leukocyte antigen, intestinal biopsy, serology",
author = "Mills, {John R.} and Murray, {Joseph A}",
year = "2016",
month = "3",
day = "1",
doi = "10.1097/MOG.0000000000000245",
language = "English (US)",
volume = "32",
pages = "80--85",
journal = "Current Opinion in Gastroenterology",
issn = "0267-1379",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Contemporary celiac disease diagnosis

T2 - Is a biopsy avoidable?

AU - Mills, John R.

AU - Murray, Joseph A

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Purpose of review The duodenal biopsy is the gold standard for the diagnosis of celiac disease. However, given improvements in the performance of serological testing, the possibility of accurately diagnosing celiac disease without the need of a biopsy has attracted interest. The European Society for Paediatric Gastroenterology, Hepatology and Nutrition has revised its recommendations to include a diagnostic algorithm that includes sequential serological testing and human leukocyte antigen genotyping for symptomatic children which would enable a diagnosis of celiac disease to be made in the absence of a confirmatory intestinal biopsy. Recent findings Recent studies have evaluated the ESPGHAN guidelines and have mostly corroborated that celiac disease can be accurately diagnosed in specific pediatric patient populations without the need of a biopsy. However, two cautionary points have been raised that warrant further consideration-the success of this approach is highly dependent targeting a population with a high pretest probability of celiac disease, as well, the performance of serology assays must be established and the appropriate use of cutoffs is essential. Summary The duodenal biopsy will remain the gold standard for diagnosing celiac disease in a majority of patients. However, as serology assays evolve and as a greater understanding of the genetic risk factors of celiac disease is achieved, more patients may be accurately diagnosed without the need for a biopsy.

AB - Purpose of review The duodenal biopsy is the gold standard for the diagnosis of celiac disease. However, given improvements in the performance of serological testing, the possibility of accurately diagnosing celiac disease without the need of a biopsy has attracted interest. The European Society for Paediatric Gastroenterology, Hepatology and Nutrition has revised its recommendations to include a diagnostic algorithm that includes sequential serological testing and human leukocyte antigen genotyping for symptomatic children which would enable a diagnosis of celiac disease to be made in the absence of a confirmatory intestinal biopsy. Recent findings Recent studies have evaluated the ESPGHAN guidelines and have mostly corroborated that celiac disease can be accurately diagnosed in specific pediatric patient populations without the need of a biopsy. However, two cautionary points have been raised that warrant further consideration-the success of this approach is highly dependent targeting a population with a high pretest probability of celiac disease, as well, the performance of serology assays must be established and the appropriate use of cutoffs is essential. Summary The duodenal biopsy will remain the gold standard for diagnosing celiac disease in a majority of patients. However, as serology assays evolve and as a greater understanding of the genetic risk factors of celiac disease is achieved, more patients may be accurately diagnosed without the need for a biopsy.

KW - celiac disease

KW - human leukocyte antigen

KW - intestinal biopsy

KW - serology

UR - http://www.scopus.com/inward/record.url?scp=84956945054&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956945054&partnerID=8YFLogxK

U2 - 10.1097/MOG.0000000000000245

DO - 10.1097/MOG.0000000000000245

M3 - Review article

C2 - 26784474

AN - SCOPUS:84956945054

VL - 32

SP - 80

EP - 85

JO - Current Opinion in Gastroenterology

JF - Current Opinion in Gastroenterology

SN - 0267-1379

IS - 2

ER -